Acorah Software Products - Accounts Production 19.2.350 false true false true No description of principal activity 21 August 2024 31 August 2025 31 August 2025 15909610 Mrs Swetaben Amit Rathod iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15909610 2024-08-20 15909610 2025-08-31 15909610 2024-08-21 2025-08-31 15909610 frs-core:CurrentFinancialInstruments 2025-08-31 15909610 frs-bus:PrivateLimitedCompanyLtd 2024-08-21 2025-08-31 15909610 frs-bus:FilletedAccounts 2024-08-21 2025-08-31 15909610 frs-bus:Micro-entities 2024-08-21 2025-08-31 15909610 frs-bus:AuditExempt-NoAccountantsReport 2024-08-21 2025-08-31 15909610 frs-bus:Director1 2024-08-21 2025-08-31
Registered number: 15909610
Ananta Pharma Limited
Financial Statements
For the Period 21 August 2024 to 31 August 2025
Balance Sheet
Registered number: 15909610
31 August 2025
£
Fixed assets 120,899
Current assets 48,895
Creditors: Amounts Falling Due Within One Year (156,608 )
NET CURRENT LIABILITIES (107,713 )
TOTAL ASSETS LESS CURRENT LIABILITIES 13,186
NET ASSETS 13,186
CAPITAL AND RESERVES 13,186

Notes

1. General Information
Ananta Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15909610 . The registered office is 64, Greenford Gardens,, Greenford, Middlesex, United Kingdom, UB6 9LZ.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mrs Swetaben Amit Rathod
Director
3 March 2026